Acute Ischemic Stroke Diagnosis Market By Technology (Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, Others) , By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Laboratories and Imaging Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Acute Ischemic Stroke Diagnosis Market
The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.
Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.
However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.
Segment Review
The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.
Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.
Region wise, North America is poised to be the highest revenue generator by 2023.
Competition Analysis
The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Key Market Segments
By Technology
Computed Tomography
Magnetic Resonance Imaging
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others
By End User
Hospitals and Clinics
Ambulatory Surgery Centers
Diagnostic Laboratories and Imaging Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Koninklijke Philips N.V.
GE Healthcare
Canon Inc.
Simens
Terumo Corporation
Stryker
Fujifilm Holdings Corporation
Samsung Electronics Co. Ltd
F. Hoffmann-La Roche Ltd
Boehringer Ingelheim International GmbH
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Technology
- 4.2. Computed Tomography
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Magnetic Resonance Imaging
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Carotid Ultrasound
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Cerebral Angiography
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- 4.6. Electrocardiography
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
- 4.7. Echocardiography
- 4.7.1. Key Market Trends, Growth Factors and Opportunities
- 4.7.2. Market Size and Forecast, By Region
- 4.7.3. Market Share Analysis, By Country
- 4.8. Others
- 4.8.1. Key Market Trends, Growth Factors and Opportunities
- 4.8.2. Market Size and Forecast, By Region
- 4.8.3. Market Share Analysis, By Country
- CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospitals And Clinics
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Ambulatory Surgery Centers
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Diagnostic Laboratories And Imaging Centers
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Technology
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Acute Ischemic Stroke Diagnosis Market
- 6.2.5.1. Market Size and Forecast, By Technology
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Acute Ischemic Stroke Diagnosis Market
- 6.2.6.1. Market Size and Forecast, By Technology
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Acute Ischemic Stroke Diagnosis Market
- 6.2.7.1. Market Size and Forecast, By Technology
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Technology
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. Germany Acute Ischemic Stroke Diagnosis Market
- 6.3.5.1. Market Size and Forecast, By Technology
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. France Acute Ischemic Stroke Diagnosis Market
- 6.3.6.1. Market Size and Forecast, By Technology
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. UK Acute Ischemic Stroke Diagnosis Market
- 6.3.7.1. Market Size and Forecast, By Technology
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Italy Acute Ischemic Stroke Diagnosis Market
- 6.3.8.1. Market Size and Forecast, By Technology
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. Spain Acute Ischemic Stroke Diagnosis Market
- 6.3.9.1. Market Size and Forecast, By Technology
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest Of Europe Acute Ischemic Stroke Diagnosis Market
- 6.3.10.1. Market Size and Forecast, By Technology
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Technology
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. Japan Acute Ischemic Stroke Diagnosis Market
- 6.4.5.1. Market Size and Forecast, By Technology
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. China Acute Ischemic Stroke Diagnosis Market
- 6.4.6.1. Market Size and Forecast, By Technology
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Acute Ischemic Stroke Diagnosis Market
- 6.4.7.1. Market Size and Forecast, By Technology
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. Australia Acute Ischemic Stroke Diagnosis Market
- 6.4.8.1. Market Size and Forecast, By Technology
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. South Korea Acute Ischemic Stroke Diagnosis Market
- 6.4.9.1. Market Size and Forecast, By Technology
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis Market
- 6.4.10.1. Market Size and Forecast, By Technology
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Technology
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Acute Ischemic Stroke Diagnosis Market
- 6.5.5.1. Market Size and Forecast, By Technology
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. Saudi Arabia Acute Ischemic Stroke Diagnosis Market
- 6.5.6.1. Market Size and Forecast, By Technology
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. South Africa Acute Ischemic Stroke Diagnosis Market
- 6.5.7.1. Market Size and Forecast, By Technology
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Acute Ischemic Stroke Diagnosis Market
- 6.5.8.1. Market Size and Forecast, By Technology
- 6.5.8.2. Market Size and Forecast, By End User
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
- CHAPTER 8: COMPANY PROFILES
- 8.1. Koninklijke Philips N.V.
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. GE Healthcare
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Canon Inc.
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Simens
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Terumo Corporation
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Stryker
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Fujifilm Holdings Corporation
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Samsung Electronics Co. Ltd
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. F. Hoffmann-La Roche Ltd
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Boehringer Ingelheim International GmbH
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CAROTID ULTRASOUND, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CEREBRAL ANGIOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ELECTROCARDIOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ECHOCARDIOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 10. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR DIAGNOSTIC LABORATORIES AND IMAGING CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 18. U.S. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 20. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 23. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 24. EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 25. EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 26. EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 27. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 28. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 30. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 31. UK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 32. UK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 33. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 34. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 35. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 36. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 37. REST OF EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 38. REST OF EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 40. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 41. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 43. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 45. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 46. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 47. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 49. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 50. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 51. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 52. REST OF ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 53. REST OF ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 55. LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 56. LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 58. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 59. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 60. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 61. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 62. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. REST OF LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
- TABLE 64. REST OF LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 65. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
- TABLE 66. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 67. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
- TABLE 68. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 69. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 70. GE HEALTHCARE: KEY EXECUTIVES
- TABLE 71. GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 72. GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 73. GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 74. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 75. CANON INC.: KEY EXECUTIVES
- TABLE 76. CANON INC.: COMPANY SNAPSHOT
- TABLE 77. CANON INC.: OPERATING SEGMENTS
- TABLE 78. CANON INC.: PRODUCT PORTFOLIO
- TABLE 79. CANON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 80. SIMENS: KEY EXECUTIVES
- TABLE 81. SIMENS: COMPANY SNAPSHOT
- TABLE 82. SIMENS: OPERATING SEGMENTS
- TABLE 83. SIMENS: PRODUCT PORTFOLIO
- TABLE 84. SIMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 85. TERUMO CORPORATION: KEY EXECUTIVES
- TABLE 86. TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 87. TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 88. TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 89. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. STRYKER : KEY EXECUTIVES
- TABLE 91. STRYKER : COMPANY SNAPSHOT
- TABLE 92. STRYKER : OPERATING SEGMENTS
- TABLE 93. STRYKER : PRODUCT PORTFOLIO
- TABLE 94. STRYKER : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. FUJIFILM HOLDINGS CORPORATION: KEY EXECUTIVES
- TABLE 96. FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
- TABLE 97. FUJIFILM HOLDINGS CORPORATION: OPERATING SEGMENTS
- TABLE 98. FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO
- TABLE 99. FUJIFILM HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. SAMSUNG ELECTRONICS CO. LTD: KEY EXECUTIVES
- TABLE 101. SAMSUNG ELECTRONICS CO. LTD: COMPANY SNAPSHOT
- TABLE 102. SAMSUNG ELECTRONICS CO. LTD: OPERATING SEGMENTS
- TABLE 103. SAMSUNG ELECTRONICS CO. LTD: PRODUCT PORTFOLIO
- TABLE 104. SAMSUNG ELECTRONICS CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
- TABLE 106. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
- TABLE 107. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
- TABLE 108. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
- TABLE 109. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY EXECUTIVES
- TABLE 111. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
- TABLE 112. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: OPERATING SEGMENTS
- TABLE 113. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
- TABLE 114. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALACUTE ISCHEMIC STROKE DIAGNOSIS MARKET
- FIGURE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION, BY TECHNOLOGY
- FIGURE 11. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CAROTID ULTRASOUND, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CEREBRAL ANGIOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ELECTROCARDIOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ECHOCARDIOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION, BY END USER
- FIGURE 19. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR DIAGNOSTIC LABORATORIES AND IMAGING CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 27. COMPETITIVE DASHBOARD
- FIGURE 28. COMPETITIVE HEATMAP: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET
- FIGURE 29. TOP PLAYER POSITIONING, 2023
- FIGURE 30. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. CANON INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. CANON INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. CANON INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. SIMENS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. SIMENS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. SIMENS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. STRYKER : NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. STRYKER : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. STRYKER : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. FUJIFILM HOLDINGS CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. SAMSUNG ELECTRONICS CO. LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. SAMSUNG ELECTRONICS CO. LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. SAMSUNG ELECTRONICS CO. LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 57. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 58. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 59. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook